| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.099 | 0.0007 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0009 |